The ups and downs of tannins as inhibitors of poly(ADP-ribose) glycohydrolase

Molecules

Volumn 16, Issue 2, 2011, Pages 1854-1877

  Blenn, Christian ^a   Wyrsch, Philippe ^a   Althaus, Felix R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Gallotannin; PARG; Poly(ADP ribose); Tannic acid; Tannin

Indexed keywords

GLYCOSIDASE; POLY ADP RIBOSE GLYCOHYDROLASE; POLY ADP-RIBOSE GLYCOHYDROLASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); TANNIN DERIVATIVE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; REVIEW; RNA INTERFERENCE;

ANIMALS; GLYCOSIDE HYDROLASES; HUMANS; MOLECULAR STRUCTURE; POLY ADENOSINE DIPHOSPHATE RIBOSE; RNA INTERFERENCE; TANNINS;

EID: 79952148357     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16021854     Document Type: Review

References (91)

1. Hottiger, M. O.; Hassa, P. O.; Luscher, B.; Schuler, H.; Koch-Nolte, F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 2010, 35, 208-219.
2. Hassa, P. O.; Haenni, S. S.; Elser, M.; Hottiger, M. O. Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol. Mol. Biol. Rev. 2006, 70, 789-829. (Pubitemid 44484693)
3. D'Amours, D.; Desnoyers, S.; D'Silva, I.; Poirier, G. G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 1999, 342 ( Pt 2), 249-268. (Pubitemid 29425344)
4. Hassa, P. O.; Hottiger, M. O. An epigenetic code for DNA damage repair pathways? Biochem. Cell Biol. 2005, 83, 270-285. (Pubitemid 41297197)
5. Chambon, P.; Weill, J. D.; Mandel, P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem. Biophys. Res. Commun. 1963, 11, 39-43.
6. Ame, J. C.; Spenlehauer, C.; de Murcia, G. The PARP superfamily. Bioessays. 2004, 26, 882-893. (Pubitemid 39128102)
7. Schreiber, V.; Dantzer, F.; Ame, J. C.; de Murcia, G. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 2006, 7, 517-528. (Pubitemid 44036457)
8. Ame, J. C.; Rolli, V.; Schreiber, V.; Niedergang, C.; Apiou, F.; Decker, P.; Muller, S.; Hoger, T.; Menissier-de Murcia, J.; de Murcia, G. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J. Biol. Chem. 1999, 274, 17860-17868.
9. Schreiber, V.; Ame, J. C.; Dolle, P.; Schultz, I.; Rinaldi, B.; Fraulob, V.; Menissier-de Murcia, J.; de Murcia, G. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J. Biol. Chem. 2002, 277, 23028-23036. (Pubitemid 34967289)
10. Ame, J. C.; Schreiber, V.; Fraulob, V.; Dolle, P.; de Murcia, G.; Niedergang, C. P. A bidirectional promoter connects the poly(ADP-ribose) polymerase 2 (PARP-2) gene to the gene for RNase P RNA. structure and expression of the mouse PARP-2 gene. J. Biol. Chem. 2001, 276, 11092-11099. (Pubitemid 38089292)
11. Sallmann, F. R.; Vodenicharov, M. D.; Wang, Z. Q.; Poirier, G. G. Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks. J. Biol. Chem. 2000, 275, 15504-15511. (Pubitemid 30337283)
12. Davidovic, L.; Vodenicharov, M.; Affar, E. B.; Poirier, G. G. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp. Cell. Res. 2001, 268, 7-13. (Pubitemid 32678855)
13. Brochu, G.; Duchaine, C.; Thibeault, L.; Lagueux, J.; Shah, G. M.; Poirier, G. G. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Acta 1994, 1219, 342-350. (Pubitemid 24319693)
14. Hatakeyama, K.; Nemoto, Y.; Ueda, K.; Hayaishi, O. Purification and characterization of poly(ADP-ribose) glycohydrolase. Different modes of action on large and small poly(ADPribose). J. Biol. Chem. 1986, 261, 14902-14911. (Pubitemid 17218047)
15. Fisher, A. E.; Hochegger, H.; Takeda, S.; Caldecott, K. W. Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase. Mol. Cell. Biol. 2007, 27, 5597-5605. (Pubitemid 47124411)
16. Cohausz, O.; Blenn, C.; Malanga, M.; Althaus, F. R. The roles of poly(ADP-ribose)-metabolizing enzymes in alkylation-induced cell death. Cell. Mol. Life Sci. 2008, 65, 644-655.
17. Blenn, C.; Althaus, F. R.; Malanga, M. Poly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death. Biochem. J. 2006, 396, 419-429. (Pubitemid 44228157)
18. Pleschke, J. M.; Kleczkowska, H. E.; Strohm, M.; Althaus, F. R. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J. Biol. Chem. 2000, 275, 40974-40980. (Pubitemid 32054922)
19. Malanga, M.; Althaus, F. R. The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem. Cell. Biol. 2005, 83, 354-364. (Pubitemid 41297203)
20. Haince, J. F.; Kozlov, S.; Dawson, V. L.; Dawson, T. M.; Hendzel, M. J.; Lavin, M. F.; Poirier, G. G. Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADPribose)- dependent pathway in the early response to DNA-damaging agents. J. Biol. Chem. 2007, 282, 16441-16453. (Pubitemid 47100334)
21. Haince, J. F.; McDonald, D.; Rodrigue, A.; Dery, U.; Masson, J. Y.; Hendzel, M. J.; Poirier, G. G. PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J. Biol. Chem. 2008, 283, 1197-1208.
22. Quenet, D.; El Ramy, R.; Schreiber, V.; Dantzer, F. The role of poly(ADP-ribosyl)ation in epigenetic events. Int. J. Biochem. Cell Biol. 2009, 41, 60-65.
23. Caiafa, P.; Guastafierro, T.; Zampieri, M. Epigenetics: Poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. FASEB J. 2009, 23, 672-678.
24. Kraus, W. L. Transcriptional control by PARP-1: Chromatin modulation, enhancer-binding, coregulation, and insulation. Curr. Opin. Cell Biol. 2008, 20, 294-302.
25. Aguilar-Quesada, R.; Munoz-Gamez, J. A.; Martin-Oliva, D.; Peralta-Leal, A.; Quiles-Perez, R.; Rodriguez-Vargas, J. M.; Ruiz de Almodovar, M.; Conde, C.; Ruiz-Extremera, A.; Oliver, F. J. Modulation of transcription by PARP-1: Consequences in carcinogenesis and inflammation. Curr. Med. Chem. 2007, 14, 1179-1187. (Pubitemid 46739319)
26. Andrabi, S. A.; Kim, N. S.; Yu, S. W.; Wang, H.; Koh, D. W.; Sasaki, M.; Klaus, J. A.; Otsuka, T.; Zhang, Z.; Koehler, R. C.; Hurn, P. D.; Poirier, G. G.; Dawson, V. L.; Dawson, T. M. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl. Acad. Sci. USA 2006, 103, 18308-18313. (Pubitemid 44871654)
27. Buelow, B.; Song, Y.; Scharenberg, A. M. The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes. J. Biol. Chem. 2008, 283, 24571-24583.
28. Fonfria, E.; Marshall, I. C.; Benham, C. D.; Boyfield, I.; Brown, J. D.; Hill, K.; Hughes, J. P.; Skaper, S. D.; McNulty, S. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br. J. Pharmacol. 2004, 143, 186-192. (Pubitemid 39280038)
29. Heeres, J. T.; Hergenrother, P. J. Poly(ADP-ribose) makes a date with death. Curr. Opin. Chem. Biol. 2007, 11, 644-653. (Pubitemid 350180567)
30. Blenn, C.; Wyrsch, P.; Bader, J.; Bollhalder, M.; Althaus, F. R. Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca(2+) fluxes in oxidative cell death. Cell. Mol. Life Sci. 20110.
31. Drew, Y.; Mulligan, E. A.; Vong, W. T.; Thomas, H. D.; Kahn, S.; Kyle, S.; Mukhopadhyay, A.; Los, G.; Hostomsky, Z.; Plummer, E. R.; Edmondson, R. J.; Curtin, N. J. Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2. J. Natl. Cancer. Inst. 2010.
32. Weston, V. J.; Oldreive, C. E.; Skowronska, A.; Oscier, D. G.; Pratt, G.; Dyer, M. J.; Smith, G.; Powell, J. E.; Rudzki, Z.; Kearns, P.; Moss, P. A.; Taylor, A. M.; Stankovic, T. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood. 2010, 116, 4578-4587.
33. Hutchinson, L. Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations. Nat. Rev. Clin. Oncol. 2010, 7, 549.
34. Schult, C.; Dahlhaus, M.; Ruck, S.; Sawitzky, M.; Amoroso, F.; Lange, S.; Etro, D.; Glass, A.; Fuellen, G.; Boldt, S.; Wolkenhauer, O.; Neri, L. M.; Freund, M.; Junghanss, C. The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells. BMC Cancer. 2010, 10, 560.
35. Yap, T. A.; Sandhu, S. K.; Carden, C. P.; de Bono, J. S. Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic. CA Cancer J. Clin. 2011.
36. Carey, L. A.; Sharpless, N. E. PARP and Cancer - If It's Broke, Don't Fix It. N. Engl. J. Med. 2011, submitted.
37. Cortes, U.; Tong, W. M.; Coyle, D. L.; Meyer-Ficca, M. L.; Meyer, R. G.; Petrilli, V.; Herceg, Z.; Jacobson, E. L.; Jacobson, M. K.; Wang, Z. Q. Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol. Cell Biol. 2004, 24, 7163-7178. (Pubitemid 39014442)
38. Whatcott, C. J.; Meyer-Ficca, M. L.; Meyer, R. G.; Jacobson, M. K. A specific isoform of poly(ADP-ribose) glycohydrolase is targeted to the mitochondrial matrix by a N-terminal mitochondrial targeting sequence. Exp. Cell Res. 2009, 315, 3477-3485.
39. Meyer, R. G.; Meyer-Ficca, M. L.; Whatcott, C. J.; Jacobson, E. L.; Jacobson, M. K. Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity. Exp. Cell Res. 2007, 313, 2920-2936. (Pubitemid 47126430)
40. Meyer-Ficca, M. L.; Meyer, R. G.; Coyle, D. L.; Jacobson, E. L.; Jacobson, M. K. Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp. Cell Res. 2004, 297, 521-532. (Pubitemid 38798412)
41. Koh, D. W.; Lawler, A. M.; Poitras, M. F.; Sasaki, M.; Wattler, S.; Nehls, M. C.; Stoger, T.; Poirier, G. G.; Dawson, V. L.; Dawson, T. M. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc. Natl. Acad. Sci. USA 2004, 101, 17699-17704. (Pubitemid 40051949)
42. Zhou, Y.; Feng, X.; Koh, D. W. Enhanced DNA accessibility and increased DNA damage induced by the absence of poly(ADP-ribose) hydrolysis. Biochemistry 2010, 49, 7360-7366.
43. Cuzzocrea, S.; Di Paola, R.; Mazzon, E.; Cortes, U.; Genovese, T.; Muia, C.; Li, W.; Xu, W.; Li, J. H.; Zhang, J.; Wang, Z. Q. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion. FASEB J. 2005, 19, 558-566. (Pubitemid 40471247)
44. Patel, N. S.; Cortes, U.; Di Poala, R.; Mazzon, E.; Mota-Filipe, H.; Cuzzocrea, S.; Wang, Z. Q.; Thiemermann, C. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 2005, 16, 712-719. (Pubitemid 41725108)
45. Min, W.; Cortes, U.; Herceg, Z.; Tong, W. M.; Wang, Z. Q. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis. Carcinogenesis 2010, 31, 2058-2065.
46. Gao, H.; Coyle, D. L.; Meyer-Ficca, M. L.; Meyer, R. G.; Jacobson, E. L.; Wang, Z. Q.; Jacobson, M. K. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase. Exp. Cell Res. 2007, 313, 984-996. (Pubitemid 46290564)
47. Meyer-Ficca, M. L.; Ihara, M.; Lonchar, J. D.; Meistrich, M. L.; Austin, C. A.; Min, W.; Wang, Z. Q.; Meyer, R. G. Poly(ADP-ribose) Metabolism Is Essential for Proper Nucleoprotein Exchange During Mouse Spermiogenesis. Biol. Reprod. 2011, 84, 218-228.
48. Meyer-Ficca, M. L.; Lonchar, J.; Credidio, C.; Ihara, M.; Li, Y.; Wang, Z. Q.; Meyer, R. G. Disruption of poly(ADP-ribose) homeostasis affects spermiogenesis and sperm chromatin integrity in mice. Biol. Reprod. 2009, 81, 46-55.
49. Ame, J. C.; Fouquerel, E.; Gauthier, L. R.; Biard, D.; Boussin, F. D.; Dantzer, F.; de Murcia, G.; Schreiber, V. Radiation-induced mitotic catastrophe in PARG-deficient cells. J. Cell Sci. 2009, 122, 1990-2002.
50. Yu, S. W.; Wang, H.; Poitras, M. F.; Coombs, C.; Bowers, W. J.; Federoff, H. J.; Poirier, G. G.; Dawson, T. M.; Dawson, V. L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297, 259-263. (Pubitemid 34761289)
51. Tanuma, S.; Sakagami, H.; Endo, H. Inhibitory effect of tannin on poly(ADP-ribose) glycohydrolase from human placenta. Biochem. Int. 1989, 18, 701-708. (Pubitemid 19135102)
52. Haslam, E. Natural polyphenols (vegetable tannins) as drugs: Possible modes of action. J. Nat. Prod. 1996, 59, 205-215. (Pubitemid 27079849)
53. Serrano, J.; Puupponen-Pimia, R.; Dauer, A.; Aura, A. M.; Saura-Calixto, F. Tannins: Current knowledge of food sources, intake, bioavailability and biological effects. Mol. Nutr. Food Res. 2009, 53(Suppl. 2), S310-329.
54. Tsai, Y. J.; Abe, H.; Maruta, H.; Hatano, T.; Nishina, H.; Sakagami, H.; Okuda, T.; Tanuma, S. Effects of chemically defined tannins on poly (ADP-ribose) glycohydrolase activity. Biochem. Int. 1991, 24, 889-897.
55. Aoki, K.; Nishimura, K.; Abe, H.; Maruta, H.; Sakagami, H.; Hatano, T.; Okuda, T.; Yoshida, T.; Tsai, Y. J.; Uchiumi, F.; et al. Novel inhibitors of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Acta 1993, 1158, 251-256. (Pubitemid 23349000)
56. Tsai, Y. J.; Aoki, T.; Maruta, H.; Abe, H.; Sakagami, H.; Hatano, T.; Okuda, T.; Tanuma, S. Mouse mammary tumor virus gene expression is suppressed by oligomeric ellagitannins, novel inhibitors of poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 1992, 267, 14436-14442.
57. Aoki, K.; Maruta, H.; Uchiumi, F.; Hatano, T.; Yoshida, T.; Tanuma, S. A macrocircular ellagitannin, oenothein B, suppresses mouse mammary tumor gene expression via inhibition of poly(ADP-ribose) glycohydrolase. Biochem. Biophys. Res. Commun. 1995, 210, 329-337.
58. Formentini, L.; Arapistas, P.; Pittelli, M.; Jacomelli, M.; Pitozzi, V.; Menichetti, S.; Romani, A.; Giovannelli, L.; Moroni, F.; Chiarugi, A. Mono-galloyl glucose derivatives are potent poly(ADPribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death. Br. J. Pharmacol. 2008, 155, 1235-1249.
59. Koh, D. W.; Coyle, D. L.; Mehta, N.; Ramsinghani, S.; Kim, H.; Slama, J. T.; Jacobson, M. K. SAR analysis of adenosine diphosphate (hydroxymethyl) pyrrolidinediol inhibition of poly(ADPribose) glycohydrolase. J. Med. Chem. 2003, 46, 4322-4332. (Pubitemid 37153013)
60. Putt, K. S.; Hergenrother, P. J. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): Application to inhibitor identification and evaluation. Anal. Biochem. 2004, 333, 256-264. (Pubitemid 39278047)
61. Okita, N.; Ashizawa, D.; Ohta, R.; Abe, H.; Tanuma, S. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADPribose). Biochem. Biophys. Res. Commun. 2010, 392, 485-489.
62. Slama, J. T.; Aboul-Ela, N.; Goli, D. M.; Cheesman, B. V.; Simmons, A. M.; Jacobson, M. K. Specific inhibition of poly(ADP-ribose) glycohydrolase by adenosine diphosphate (hydroxymethyl)pyrrolidinediol. J. Med. Chem. 1995, 38, 389-393.
63. Lu, X. C.; Massuda, E.; Lin, Q.; Li, W.; Li, J. H.; Zhang, J. Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res. 2003, 978, 99-103. (Pubitemid 36776629)
64. Genovese, T.; Di Paola, R.; Catalano, P.; Li, J. H.; Xu, W.; Massuda, E.; Caputi, A. P.; Zhang, J.; Cuzzocrea, S. Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice. Crit. Care Med. 2004, 32, 1365-1374. (Pubitemid 38738594)
65. Miwa, M.; Tanaka, M.; Matsushima, T.; Sugimura, T. Purification and properties of glycohydrolase from calf thymus splitting ribose-ribose linkages of poly(adenosine diphosphate ribose). J. Biol. Chem. 1974, 249, 3475-3482.
66. Keil, C.; Petermann, E.; Oei, S. L. Tannins elevate the level of poly(ADP-ribose) in HeLa cell extracts. Arch. Biochem. Biophys. 2004, 425, 115-121. (Pubitemid 38479610)
67. Falsig, J.; Christiansen, S. H.; Feuerhahn, S.; Burkle, A.; Oei, S. L.; Keil, C.; Leist, M. Poly(ADPribose) glycohydrolase as a target for neuroprotective intervention: Assessment of currently available pharmacological tools. Eur. J. Pharmacol. 2004, 497, 7-16. (Pubitemid 39092421)
68. Mullen, W.; McGinn, J.; Lean, M. E.; MacLean, M. R.; Gardner, P.; Duthie, G. G.; Yokota, T.; Crozier, A. Ellagitannins, flavonoids, and other phenolics in red raspberries and their contribution to antioxidant capacity and vasorelaxation properties. J. Agric. Food Chem. 2002, 50, 5191-5196. (Pubitemid 34925111)
69. Espin, J. C.; Garcia-Conesa, M. T.; Tomas-Barberan, F. A. Nutraceuticals: Facts and fiction. Phytochemistry. 2007, 68, 2986-3008. (Pubitemid 350180953)
70. Gonzalez-Barrio, R.; Borges, G.; Mullen, W.; Crozier, A. Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J. Agric. Food Chem. 2010, 58, 3933-3939.
71. Borges, G.; Mullen, W.; Mullan, A.; Lean, M. E.; Roberts, S. A.; Crozier, A. Bioavailability of multiple components following acute ingestion of a polyphenol-rich juice drink. Mol. Nutr. Food Res. 2010, 54 (Suppl. 2), S268-S277.
72. Uchiumi, F.; Maruta, H.; Inoue, J.; Yamamoto, T.; Tanuma, S. Inhibitory effect of tannic acid on human immunodeficiency virus promoter activity induced by 12-O-tetra decanoylphorbol-13- acetate in Jurkat T-cells. Biochem. Biophys. Res. Commun. 1996, 220, 411-417.
73. Uchiumi, F.; Hatano, T.; Ito, H.; Yoshida, T.; Tanuma, S. Transcriptional suppression of the HIV promoter by natural compounds. Antivir. Res. 2003, 58, 89-98. (Pubitemid 36507226)
74. Uchiumi, F.; Ikeda, D.; Tanuma, S. Changes in the activities and gene expressions of poly(ADPribose) glycohydrolases during the differentiation of human promyelocytic leukemia cell line HL- 60. Biochim. Biophys. Acta 2004, 1676, 1-11. (Pubitemid 38367725)
75. Ying, W.; Swanson, R. A. The poly(ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death. Neuroreport 2000, 11, 1385-1388. (Pubitemid 30365472)
76. Ying, W.; Sevigny, M. B.; Chen, Y.; Swanson, R. A. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. USA 2001, 98, 12227-12232. (Pubitemid 32959855)
77. Bakondi, E.; Bai, P.; Erdelyi, K.; Szabo, C.; Gergely, P.; Virag, L. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: The role of poly(ADP-ribose) metabolism. Exp. Dermatol. 2004, 13, 170-178. (Pubitemid 38380281)
78. Di Meglio, S.; Tramontano, F.; Cimmino, G.; Jones, R.; Quesada, P. Dual role for poly(ADPribose) polymerase-1 and -2 and poly(ADP-ribose)glycohydrolase as DNA-repair and proapoptotic factors in rat germinal cells exposed to nitric oxide donors. Biochim. Biophys. Acta 2004, 1692, 35-44. (Pubitemid 38670259)
79. Dumitriu, I. E.; Voll, R. E.; Kolowos, W.; Gaipl, U. S.; Heyder, P.; Kalden, J. R.; Herrmann, M. UV irradiation inhibits ABC transporters via generation of ADP-ribose by concerted action of poly(ADP-ribose) polymerase-1 and glycohydrolase. Cell Death Differ. 2004, 11, 314-320. (Pubitemid 38313140)
80. Rapizzi, E.; Fossati, S.; Moroni, F.; Chiarugi, A. Inhibition of poly(ADP-ribose) glycohydrolase by gallotannin selectively up-regulates expression of proinflammatory genes. Mol. Pharmacol. 2004, 66, 890-898. (Pubitemid 39319461)
81. Erdelyi, K.; Kiss, A.; Bakondi, E.; Bai, P.; Szabo, C.; Gergely, P.; Erdodi, F.; Virag, L. Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells. Mol. Pharmacol. 2005, 68, 895-904. (Pubitemid 41206046)
82. Maruta, H.; Okita, N.; Takasawa, R.; Uchiumi, F.; Hatano, T.; Tanuma, S. The involvement of ATP produced via (ADP-Ribose)n in the maintenance of DNA replication apparatus during DNA repair. Biol. Pharm. Bull. 2007, 30, 447-450. (Pubitemid 46355920)
83. Tikoo, K.; Sane, M. S.; Gupta, C. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: Potential role of tannins in cancer chemotherapy. Toxicol. Appl. Pharmacol. 2010.
84. Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Snow, B. E.; Brothers, G. M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; Larochette, N.; Goodlett, D. R.; Aebersold, R.; Siderovski, D. P.; Penninger, J. M.; Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397, 441-446.
85. Artus, C.; Boujrad, H.; Bouharrour, A.; Brunelle, M. N.; Hoos, S.; Yuste, V. J.; Lenormand, P.; Rousselle, J. C.; Namane, A.; England, P.; Lorenzo, H. K.; Susin, S. A. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J. 2010, 29, 1585-1599.
86. Wang, H.; Yu, S. W.; Koh, D. W.; Lew, J.; Coombs, C.; Bowers, W.; Federoff, H. J.; Poirier, G. G.; Dawson, T. M.; Dawson, V. L. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci. 2004, 24, 10963-10973. (Pubitemid 39602407)
87. Moubarak, R. S.; Yuste, V. J.; Artus, C.; Bouharrour, A.; Greer, P. A.; Menissier-de Murcia, J.; Susin, S. A. Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol. Cell Biol. 2007, 27, 4844-4862. (Pubitemid 47016136)
88. Chandak, P. G.; Gaikwad, A. B.; Tikoo, K. Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP. Phytother. Res. 2009, 23, 72-77.
89. Tikoo, K.; Bhatt, D. K.; Gaikwad, A. B.; Sharma, V.; Kabra, D. G. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats. FEBS Lett. 2007, 581, 2027-2035. (Pubitemid 46670130)
90. Tikoo, K.; Tamta, A.; Ali, I. Y.; Gupta, J.; Gaikwad, A. B. Tannic acid prevents azidothymidine (AZT) induced hepatotoxicity and genotoxicity along with change in expression of PARG and histone H3 acetylation. Toxicol. Lett. 2008, 177, 90-96.
91. Wei, G.; Wang, D.; Lu, H.; Parmentier, S.; Wang, Q.; Panter, S. S.; Frey, W. H. 2nd; Ying, W. Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury. Front. Biosci. 2007, 12, 4986-4996.